Free Trial
NASDAQ:COSM

Cosmos Health Q4 2024 Earnings Results & Report

Cosmos Health logo
$0.34 +0.02 (+6.84%)
Closing price 10/9/2026 04:00 PM Eastern
Extended Trading
$0.33 0.00 (-1.16%)
As of 10/9/2026 07:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Cosmos Health beat analyst earnings expectations but missed on revenue in its Q4 2024 results, released April 15, 2025. The company reported EPS of -$0.08 versus the -$0.09 consensus estimate, while revenue of $14.22 million fell short of the $14.50 million estimate by $0.28 million.

Earnings Announcement Details

Quarter
Q4 2024
Report Date
Time
During Market Hours

Cosmos Health EPS Results

Actual EPS
-$0.08
Consensus EPS
-$0.09
Beat/Miss
Beat by +$0.01
One Year Ago EPS
N/A
EPS Beat Rate
2 of last 6 quarters

Cosmos Health Revenue Results

Actual Revenue
$14.22 million
Expected Revenue
$14.50 million
Beat/Miss
Missed by -$280.00 thousand
YoY Revenue Growth
N/A

Upcoming Earnings

Cosmos Health's next earnings date is estimated for Friday, November 13, 2026, based on past reporting schedules.

Conference Call Resources

Cosmos Health Q4 2024 Earnings FAQ

Cosmos Health (NASDAQ:COSM) reported earnings of -$0.08 per share for Q4 2024, beating the consensus estimate of -$0.09. The report was announced on Tuesday, April 15, 2025.

Cosmos Health reported revenue of $14.22 million for Q4 2024, against a consensus estimate of $14.50 million.

Cosmos Health's next earnings date is estimated for Friday, November 13, 2026. MarketBeat tracks confirmed and estimated earnings dates for Cosmos Health on the company's earnings history page.

Cosmos Health Earnings Headlines

What’s Elon building now?
New drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and built in a matter of weeks. James Altucher says the site could go live as soon as October 21 and has put together a free presentation explaining what is happening inside and why the timing matters.tc pixel
Comparing Amplifon (OTCMKTS:AMFPF) & Cosmos Health (NASDAQ:COSM)
See More Cosmos Health Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Cosmos Health? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cosmos Health and other key companies, straight to your email.

About Cosmos Health

Cosmos Health (NASDAQ:COSM) is a global healthcare group that develops, markets and distributes pharmaceutical, nutraceutical and wellness products. The company serves consumers, healthcare professionals and commercial partners through a portfolio that includes prescription and over-the-counter medicines, dietary supplements, vitamins and other health-related products.

Cosmos Health markets proprietary nutraceutical brands, including Sky Premium Life, and offers products across categories such as vitamins, minerals, sports nutrition and general wellness. Through its pharmaceutical activities, the company is also involved in the wholesale distribution of medicines, medical products and related healthcare items.

Founded in 2009 and formerly known as Cosmos Holdings Inc., the company is headquartered in Chicago and has operations and business relationships spanning the United States, Europe and other international markets. Its European activities have included pharmaceutical distribution and manufacturing partnerships, particularly in Greece. Cosmos Health is led by Chief Executive Officer Greg Siokos, who co-founded the company.

View Cosmos Health Profile